Name: Using education and awareness to drive positive change for patients
Start: 2018-05-03T15:30:00Z
End: 2018-05-03T15:31:02.000Z
Location: BrightTALK
Rating: 0

pharmaphorum provides a digital podium for communicating thought leadership and innovation within pharma. Our webinars bring together different stakeholders from across the healthcare spectrum to drive fresh thinking and novel solutions that deliver better outcomes for patients.

Explore “Innovation as Strategy” framework, providing a guide for employing innovative strategies in life sciences. These expert panellists will reflect on what ‘Innovation as Strategy’ means to them, offering their perspectives, along with practical advice and real-world examples.
If you are interested in learning more about the "Innovation as Strategy" framework, get in touch with Healthware's team at healthwaregroup.com.

Innovation as Strategy: Enabling life sciences of the future

Clinical trial delivery in the UK is evolving to take trial activities to the patients, delivering research in different ways, such as remote, decentralised, virtual or hybrid trials. Join the NIHR for the chance to learn from real-life examples as panellists explore how they overcame practical challenges to establish this model and highlight opportunities to achieve more accessible research for participants and real-world evidence.

The evolution of clinical research: embracing new delivery models in the UK

Discover how an upscaled brand planning approach can shape success by overcoming challenges: from crafting effective launch plans to optimising sales strategies, uncover these tools’ full potential, driving excellence in the intricate realm of pharmaceuticals.

Upscaling your brand strategy game with new ways of planning

Experts in clinical trial technology, design and execution will come together in a moderated discussion to explore these different facets of the opportunities created by AI, both traditional and generative.

How AI is supercharging clinical trials

As conversations surrounding Equality, Diversity, and Inclusion (EDI) in health and care research participation continue to broaden, we are also expanding our scope of involvement and inclusivity. However, achieving the ambitious goal of EDI remains a challenge.
In this interactive webinar, brought to you by the National Institute for Health and Care Research (NIHR), we delve beneath the surface of EDI in research to unpick common challenges in offering equal participation opportunities in the UK.

EDI in clinical research: The case for adaptive strategies at every step

A panel of industry experts will discuss how the NCVR is transforming study set-up timelines in the UK.

Revolutionising research: Inside the NCVR evolution in the UK

Bringing together industry panellists to share insights and lessons learned from their own professional lives on successful transformation with AI and omnichannel, and the hurdles that can occur along the way.

Harnessing Omnichannel, AI, and beyond: Reimagining Scientific Publications

To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to methods for incorporating patient voice in the development of new therapeutics, specifically as part of clinical trials.

Voices to Trials: Engaging Patients in Clinical Trial Design

Viewers will leave with the knowledge and tools needed to create an effective omnichannel content strategy that drives engagement with HCPs and helps achieve marketing goals.

How to cultivate a successful omnichannel strategy

What does it take to establish new treatments for rare diseases?

Trials and tribulations of drug development

Right research, right place, right time - this session focuses on how to place your study more strategically to optimise study performance.

An inside guide to unlocking clinical research in the UK – PART 2

Set your research on the right path - this session focuses on how to plan for success by getting expert advice on the deliverability of your proposed protocols.

An inside guide to unlocking clinical research in the UK – PART 1

The impact of the COVID-19 pandemic has added extra pressure onto an NHS system that was already facing challenges due to limitations on resources and budgets.

Partnering with NHS in a crisis: The role for industry

Engaging digitally native healthcare professionals requires companies to challenge existing business ethos and commit to the customer experience in an increasingly digital world.

Digital natives: are pharma companies ready?

Join us to learn about the pivotal role oncology PSPs can continue to play in cancer care, and the opportunities and challenges AI-powered digital cancer support platforms present to clinicians and drug makers. How close is the vision and promise to reality, and how can you tap into these next-generation digital oncology platforms to create and deliver value for your patients and your organisation?

How can digital and AI optimise delivery of patient support programs in cancer?

In this webinar, brought to you by Complete HealthVizion, three experts on MSL training will discuss the current challenges and opportunities for MSLs, the skills they need to meet those challenges, and new strategies and technologies that can be used to impart those skills.

Meeting MSL training needs in an evolving landscape

Patient centricity is a high priority these days for pharma companies, who are discovering the value of letting patients’ needs guide the development of therapies and interventions, not only to the patients but to their own outcomes and bottom lines. 

But as with any culture change, it’s important to be able to measure the change and measure its affects – or is it?

In this webinar, brought to you by the company behind A Life in a Day, patient centricity experts will draw from their own experiences to debate questions around how and why to measure these initiatives. Is it important to measure impact and prove outcomes, or is it enough to improve the patient experience for its own sake? Is it even possible to create meaningful measurements for patient centric activities, and if so, what do those measurements look like?

Join us on Wednesday, 7th December at 1 pm BST as panelists share insights and lessons from their own professional life to explore these important questions.

This webinar will also explore: 

• What meaningful patient experiences can look like and how they can affect treatment outcomes
• How to leverage the voice of the patient in creating interventions
• What KPIs are important to measure and how best to measure them

Attendees will leave with energised and educated about patient centricity, how to achieve it, and how to benchmark those achievements.

What is the true value of a “patient centric” initiative?

In this webinar, sponsored by IQVIA, the panel will discuss how the Innovative Medicines Fund works, what the implications are for industry organisations in securing funding via this route, and how this will influence uptake of medicines recommended via a NICE technology appraisal.

IMF and the opportunity for ICSs to mobilise NICE approvals

Change Together will be presenting a live webinar with leading figures from the patient advocacy community, who will debate how we can drive positive change for patients through improved education and awareness. This will be helpful for all advocates, as we hear and learn from our expert panel how their organizations are bringing about change.
The panel and the topics they will be covering are as follows.
•  Dr. Gwen Nichols, Chief Medical Officer of the Leukemia & Lymphoma Society on coordinating the group’s groundbreaking Beat AML Master Trial, which is taking the latest research from the lab to the clinic.
•  Kathleen Weis, Chief Executive Officer of the Aplastic Anemia and MDS International Foundation, on the changing treatment landscape, which is bringing new hope to patients, and how her group is supporting the AML community.
•  Representatives from Know AML, the global AML awareness initiative established in 2017 – Gary Nolan from the Know AML secretariat and Brian Tomlinson, patient advocate committee member and Chief Program Officer at CancerCare – explaining how the project started and the role that patient advocates play in it.

Using education and awareness to drive positive change for patients

patient advocacy

acute myeloid leukemia

patients

education

disease awareness

Get powerful marketing insights for your business. Connect with experts and colleagues to get the most up-to-date knowledge on which marketing strategies and techniques are driving customer and revenue growth.

Marketing

The marketing community on BrightTALK is made up of thousands of engaged marketing professionals. Find relevant webinars and videos on marketing strategy, branding and more presented by recognized thought leaders. Join the conversation by participating in live webinars and round table discussions.

The medical research community on BrightTALK brings together medical and research professionals. Find relevant webinars on medical research, laboratory science, continuing medical education and more presented by recognized medical researchers. Join the conversation by participating in live webinars and round table discussions on the latest in medical devices, medical research practices and trends in the healthcare industry.

Medical Research

Get powerful life science insights from influential experts. Connect with thought leaders and colleagues to get the most up-to-date knowledge on strategies and initiatives to accelerate the transformation of U.S. and global health care from a volume- to value-based marketplace.

Using education and awareness to drive positive change for patients

Presented by

About this talk

More from this channel